The effect of beta-glucan administration on macrophage respiratory burst activity and Atlantic salmon, Salmo salar L., challenged with amoebic gill disease--evidence of inherent resistance.
Previous studies have demonstrated that beta-glucans stimulate Atlantic salmon, Salmo salar L., head kidney macrophages both in vitro and in vivo and increase protection against various pathogens. Based on our previous work that showed potent immunostimulatory CpG motif-containing oligodeoxynucleotides increased resistance to amoebic gill disease (AGD), the present study investigated the immunostimulatory effects of three commercial beta-glucan-containing feeds and their ability to increase resistance to AGD. All three commercial beta-glucans were able to stimulate the respiratory burst activity of Atlantic salmon head kidney macrophages in vitro, albeit at different times and concentrations. However, dietary incorporation of the beta-glucans was unable to stimulate the in vivo respiratory burst activity of head kidney macrophages, or serum lysozyme production, and did not increase resistance against AGD. However, this trial showed for the first time that a small subpopulation of Atlantic salmon subjected to a severe AGD infection was able to resist becoming heavily infected and furthermore survive the challenge.
Bridle
A R
AR
School of Aquaculture, Tasmanian Aquaculture and Fisheries Institute and Aquafin CRC, University of Tasmania, Launceston, Tasmania, Australia. andrew.bridle@utas.edu.au
Carter
C G
CG
Morrison
R N
RN
Nowak
B F
BF
D000821:Animal Feed; D000818:Animals; D017756:Aquaculture; D005393:Fish Diseases / Q000276:immunology* / Q000469:parasitology; D005880:Gills / Q000473:pathology; D007113:Immunity, Innate / Q000187:drug effects*; D016840:Lobosea; D008264:Macrophages / Q000378:metabolism; D011528:Protozoan Infections / Q000276:immunology; D011529:Protozoan Infections, Animal; D016897:Respiratory Burst / Q000187:drug effects*; D020317:Salmo salar; D047071:beta-Glucans / Q000494:pharmacology*
D047071:beta-Glucans